• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,883.79 -389.66
( -0.52%)
Global Indices
Nasdaq
45,986.51 -463.99
(-1.00%)
Dow Jones
6,496.71 -116.19
(-1.76%)
Hang Seng
53,366.12 -383.50
(-0.71%)
Nikkei 225
9,975.43 -131.41
(-1.30%)
Forex
USD-INR
93.86 0.07
(0.08%)
EUR-INR
108.76 0.06
(0.06%)
GBP-INR
125.66 0.01
(0.01%)
JPY-INR
0.59 0.00
(-0.13%)

EQUITY - MARKET SCREENER

Infinium Pharmachem Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78690
INE0MRE01011
67.8370031
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
INFINIUM
36.85
311.82
EPS(TTM)
Face Value()
Div & Yield %
5.43
10
0
 

sru steels ltd
Avantel rises after bagging Rs 123-cr order from NewSpace India
Feb 11,2026
The contract, covering supply, installation, and commissioning, is scheduled for completion by August 2027. Key terms include a 2.5% security deposit and a 0.5% performance bank guarantee. The order has been awarded by a domestic entity.

Avantel is engaged in the business of designing, developing, and maintaining wireless and satellite communication products, defence electronics, radar systems, and the development of network management software applications for its customers, mainly from the aerospace and defence sectors.

The company’s consolidated net profit tanked 86.4% YoY to Rs 2.74 crore in Q3 FY26, compared with Rs 20.08 crore in Q3 FY25. Revenue from operations declined 26.8% year-on-year to Rs 51.72 crore in Q3 FY26.